Quarterly Result: Aurobindo Pharma Ltd
Bhagyashree Vivarekar / 15 Nov 2016
Aurobindo Pharma Ltd., is currently trading at Rs. 77.80, up by 3.9 points or 0.51% from its earlier closing of Rs. 771.9 on the BSE. Also net profit has soared 33.5% yoy to Rs 605.65 cr, anchored by 27% yoy drop in finance costs.
Technical View:
Aurobindo Pharma Ltd., is currently trading at Rs. 77.80, up by 3.9 points or 0.51% from its earlier closing of Rs. 771.9 on the BSE. The scrip has touched a high and low of Rs. 792 and Rs. 772.6 respectively, after opening at 792.
Consolidated Results Q2FY17:
Aurobindo Pharma Ltd’s Q2FY17 consolidated numbers have come in as a mixed bag in comparison with street estimates. Revenue is 2.1% below our estimates of Rs 3856.7 cr. Auro Pharma's EBITDA is 0.9% lesser than the estimated figure of Rs 937 cr. However, net profit stands 0.6% higher than the estimates of Rs 602 cr.
Net revenue stands at Rs 3775.5 cr which has climbed 12.2% as compared to the same quarter of last year. Formulation sales to USA have climbed 17.8% yoy to Rs 1735.1 cr. Moreover, revenues from Betalactum API (Active Pharmaceutical Ingredients) have climbed 19.6% yoy to Rs 511.3 cr.
Auro's EBITDA has soared 19.3% yoy to Rs 929 cr and EBITDA margins have improved 150 bps yoy to 24.6%.
Also net profit has soared 33.5% yoy to Rs 605.65 cr, anchored by 27% yoy drop in finance costs.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.